Articles with public access mandates - James CerhanLearn more
Not available anywhere: 10
Review
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium
A Kricker, BK Armstrong, AM Hughes, C Goumas, KE Smedby, T Zheng, ...
International Journal of Cancer 122 (1), 144-154, 2008
Mandates: Canadian Institutes of Health Research
Review
High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL)
JC Pritchett, ZZ Yang, HJ Kim, JC Villasboas, X Tang, S Jalali, JR Cerhan, ...
Leukemia 36 (1), 165-176, 2022
Mandates: US National Institutes of Health
Review
B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells
F Secreto, M Manske, T Price-Troska, S Ziesmer, LS Hodge, SM Ansell, ...
Leukemia & lymphoma 55 (8), 1884-1892, 2014
Mandates: US National Institutes of Health, Lymphoma Research Foundation, USA
Review
Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy
C Bommier, E Zucca, S Chevret, A Conconi, G Nowakowski, MJ Maurer, ...
Blood 143 (5), 422-428, 2024
Mandates: National Institute of Health and Medical Research, France
Review
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine+ Rituximab in Low-grade Lymphomas
MA Moustafa, BJ Borah, JP Moriarty, R Dholakia, L Jiang, K Li, TE Witzig, ...
Clinical Lymphoma Myeloma and Leukemia 23 (4), 259-265, 2023
Mandates: US National Institutes of Health
Review
Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma
C Bommier, BK Link, B Gysbers, MJ Maurer, MC Larson, A Khurana, ...
Blood 142, 1672, 2023
Mandates: National Institute of Health and Medical Research, France
Review
Effectiveness of Chemo-Immunotherapy (CIT) and Novel Therapies in Second or Later Line of Therapy (2L+) for Patients with Relapsed/Refractory (R/R) Aggressive Large B-Cell …
LJ Nastoupil, CR Andersen, A Ayers, Y Wang, TM Habermann, D Chihara, ...
Blood 142, 309, 2023
Mandates: Wellcome Trust
Review
Risk of incident melanoma among individuals with low-count monoclonal B-cell lymphocytosis (MBL).
BA Vallejo, A Ansari, SA Parikh, SJ Achenbach, KG Rabe, A Norman, ...
Journal of Clinical Oncology 41 (16_suppl), 7577-7577, 2023
Mandates: US National Institutes of Health
Review
SOMATIC ALTERATIONS IN FOLLICULAR LYMPHOMA ASSOCIATE WITH UNIQUE TUMOR‐CELL TRANCRIPTIONAL STATES AND TUMOR‐IMMUNE MICROENVIRONMENTS
J Krull, K Wenzl, MK Manske, MA Hopper, MC Larson, V Sarangi, ...
Hematological Oncology 39, 2021
Mandates: US National Institutes of Health
Review
Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study
M Tsang, BN Noble, C Bommier, C Casulo, C Thompson, AC Rosenthal, ...
Blood 142, 3761, 2023
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 391
Review
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
The Lancet 388 (10046), 776-786, 2016
Mandates: US National Institutes of Health, British Heart Foundation, Cancer Research …
Review
Body-mass index and mortality among 1.46 million white adults
A Berrington de Gonzalez, P Hartge, JR Cerhan, AJ Flint, L Hannan, ...
New England Journal of Medicine 363 (23), 2211-2219, 2010
Mandates: US National Institutes of Health
Review
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ...
Nature medicine 24 (5), 679-690, 2018
Mandates: US National Institutes of Health, Federal Ministry of Education and Research …
Review
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
M Crump, SS Neelapu, U Farooq, E Van Den Neste, J Kuruvilla, J Westin, ...
Blood 130 (16), 1800-1808, 2017
Mandates: US National Institutes of Health
Review
Body-mass index and mortality among 1.46 million white adults.
AB De Gonzalez, P Hartge, JR Cerhan, AJ Flint, L Hannan, RJ MacInnis, ...
New England Journal of Medicine 363 (23), 2211-2219, 2010
Mandates: US National Institutes of Health
Review
2016 US lymphoid malignancy statistics by World Health Organization subtypes
LR Teras, CE DeSantis, JR Cerhan, LM Morton, A Jemal, CR Flowers
CA: a cancer journal for clinicians 66 (6), 443-459, 2016
Mandates: US National Institutes of Health, Wellcome Trust, V Foundation, USA
Review
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
JG Lohr, P Stojanov, MS Lawrence, D Auclair, B Chapuy, C Sougnez, ...
Proceedings of the National Academy of Sciences 109 (10), 3879-3884, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Type I and II endometrial cancers: have they different risk factors?
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607-2618, 2013
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from …
C Casulo, M Byrtek, KL Dawson, X Zhou, CM Farber, CR Flowers, ...
Journal of Clinical Oncology 33 (23), 2516-2522, 2015
Mandates: US National Institutes of Health
Review
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
K Ekström Smedby, CM Vajdic, M Falster, EA Engels, O Martínez-Maza, ...
Blood 111 (8), 4029-4038, 2008
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program